<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580682</url>
  </required_header>
  <id_info>
    <org_study_id>XTCX2014-SFT</org_study_id>
    <nct_id>NCT02580682</nct_id>
  </id_info>
  <brief_title>Sanfu Herbal Patch and Sanfu Moxibustion for Persistent Allergic Rhinitis: a Controlled Clinical Trial</brief_title>
  <official_title>San-fu Herbal Patch and San-fu Moxibustion for Persistent Allergic Rhinitis: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the efficacy of Sanfu herbal patch and Sanfu moxibustion on persistent allergic
      rhinitis,and comparing the differences between the combination of these 2 methods with each
      method alone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Since the treatments in this study are visualized, it is not feasible to blind the patients and therapists.Therefore, the outcome assessors will be blinded, they will not participate in the recruitment, study design and the treatment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total Nasal Symptom Score(TNSS)</measure>
    <time_frame>three years</time_frame>
    <description>In TNSS, symptoms of nasal congestion , sneezing, nasal itching and rhinorrhea are assessed by scores ranging from 0 to 3. A score of 0 indicates no symptoms, 1 for mild symptoms that are easily tolerated, 2 for awareness of symptoms which are bothersome but tolerable and 3 is reserved for severe symptoms that are hard to tolerate and interfere with daily activity .TNSS is calculated by adding the score for each symptom together</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS)</measure>
    <time_frame>three years</time_frame>
    <description>VAS is a 10cm scale to assess the impact of AR on life quality ranging from score of 0 to 10, which stands for &quot;no impact&quot; to &quot;serious impact</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rhinitis Quality of Life Questionnaire (RQLQ)</measure>
    <time_frame>three years</time_frame>
    <description>The RQLQ contains 28 questions to evaluate impairment of everyday life caused by symptoms of nose and eyes. Seven dimensions will be assessed, including daily life, sleep, non-nosal/optical symptoms, practical problems, nosal symptoms, optical symptoms and emotion. Every question should be answered by scores: 0 - not trouble, 1 - any trouble at all, 2 - somewhat troubled, 3 - moderately troubled, 4 - quite a bit of trouble, 5 - very troubled, 6 - extremely troubled.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>36-item Short-Form Health Survey (SF-36)</measure>
    <time_frame>three years</time_frame>
    <description>SF-36 consists of 36 items categorized as eight dimensions: social functioning (two items), role limitation-emotion (three items), mental health (five items), physical functioning (ten items), role limitation-physical (four items), bodily pain (two items), vitality (four items), general health (five items) and one question of health change in recent one year.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Patch,Chinese Herb</condition>
  <condition>Moxibustion</condition>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>Sanfu herbal patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one kind of acupoint application which used in hot dog days of summer,The formula of the patch consists of Huang Qi (Astagalus Membranaceus), Fu Zi (Aconiti Lateralis Radix Praeparata), Yan Hu Suo (Rhizoma Corydalis), Xi Xin (Herba asarum), Bai Jie Zi (Semen Sinapis Albae), and Rou Gui (Cortex Cinnamomi) at a ratio of 2:2:1:1:2:1.The bilateral Feishu (BL13), Pishu (BL20), Shenshu (BL23), Neiguan (PC6), and Guanyuan (CV4) acupoints were selected for treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sanfu moxibustion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use moxibustion in hot dog days of summer,and adopting the indirect moxibustion box method at the bilateral BL13, BL20, and BL23 acupoints</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sanfu herbal patch and Sanfu moxibustion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use herbal patch and moxibustion together in hot dog days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controlled</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients in this group will not accept herbal patch or moxibustion therapy in these 3 years. After the 3-year experimental period they will be offered corresponding treatments for free as well, so they are in our wait list.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanfu herbal patch</intervention_name>
    <description>The formula of the patch consists of Huang Qi (Astagalus Membranaceus), Fu Zi (Aconiti Lateralis Radix Praeparata), Yan Hu Suo (Rhizoma Corydalis), Xi Xin (Herba As5ari), Bai Jie Zi (Semen Sinapis Albae) and Rou Gui(Cortex Cinnamomi), in a proportion of 2:2:1:1:2:1.</description>
    <arm_group_label>Sanfu herbal patch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanfu moxibustion</intervention_name>
    <description>Moxibustion is a kind of thermal therapy without any feeling of pain or swell.Moxibustion exerts its therapeutic effect by thermal power and the application of moxa.</description>
    <arm_group_label>Sanfu moxibustion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sanfu herbal patch and moxibustion</intervention_name>
    <description>use Sanfu moxibustion followed by Sanfu herbal patch</description>
    <arm_group_label>Sanfu herbal patch and Sanfu moxibustion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

        Patients recruited to this study must meet the following inclusion criteria:

          1. Males or females aged between 5 and 60 years.

          2. Each PAR patient must be diagnosed by an otolaryngologist using the following
             diagnostic criteria: major symptoms of paroxysm rhinocnesmus, continuous sneezing,
             nasal obstruction, and significant quantities of clear and thin nasal mucus,
             accompanied by symptoms of hyposmia and itching of the eyes and throat. These symptoms
             should last for or add up to 1 hour a day. The attacks should occur for more than 4
             weeks and at last for at least 4 days each week.

          3. One of 2 laboratory results is positive: skin prick test or serum high circulating
             levels of allergen-specific IgE antibody detected by a specific blood test for allergy
             called a radioallergosorbent (RAST) test

          4. The course of the disease is more than 1 year.

          5. Voluntary signing of an informed consent form.

          6. No current participation in any other clinical trials. Exclusion criteria

        Patients with any of the following conditions will be excluded:

          1. Allergies to the herbal medicines, a moxa smoke or adhesive tape applied in this
             study, and the skin at the specific acupoint has physical scars or breakage.

          2. Patients with other allergic diseases, such as allergic asthma.

          3. Patients who received acupuncture and moxibustion treatment, Chinese herbal medicine,
             nasal inhalation of herbal medicine, physical therapy or other external treatment for
             AR within the last 4 weeks

          4. Patients who received immune therapy or systematic hormonotherapy in the past 1 year.

          5. Pregnant women, lactating women, or women preparing for pregnancy in 2 years.

          6. Patients with serious medical disorders such as congenital heart disease, severe
             nephropathy, mental diseases, and infectious diseases including tuberculosis,
             hepatitis, and AIDS.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fengxia Liang, Doctor</last_name>
    <phone>+86 18971371818</phone>
    <email>315938821@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hubei university of TCM</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fengxia Liang, Doctor</last_name>
      <phone>+86 18971371818</phone>
      <email>315938821@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2015</study_first_submitted>
  <study_first_submitted_qc>October 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>we have recruited approximately sixty patients in tha last year, informations including contacting numbers, medical history, questionnaires and follow-up materials, we have not decided in which way we could share these data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

